loader image
Tuesday, February 3, 2026
63.1 F
McAllen
- Advertisement -

Governor Abbott, UT System Announce New World-Class Cancer Center

Translate to Spanish or other 102 languages!

Governor Greg Abbott today joined members of The University of Texas (UT) System Board of Regents to announce a transformative partnership between UT Austin and UT MD Anderson Cancer Center to build a new hospital and comprehensive cancer care center on UT Austin’s campus, bringing the nation’s top-ranked oncology clinicians and health care providers to Austin. Photo: Office of the Governor
Governor Greg Abbott today joined members of The University of Texas (UT) System Board of Regents to announce a transformative partnership between UT Austin and UT MD Anderson Cancer Center to build a new hospital and comprehensive cancer care center on UT Austin’s campus, bringing the nation’s top-ranked oncology clinicians and health care providers to Austin. Photo: Office of the Governor

Mega Doctor News

- Advertisement -

AUSTIN, Texas – Governor Greg Abbott today joined members of The University of Texas (UT) System Board of Regents to announce a transformative partnership between UT Austin and UT MD Anderson Cancer Center to build a new hospital and comprehensive cancer care center on UT Austin’s campus, bringing the nation’s top-ranked oncology clinicians and health care providers to Austin.

Governor Abbott addressing the meeting. Photo: Office of the Governor

“The State of Texas has been on a mission to use higher education to expand access to healthcare, and today marks a giant step towards achieving our goals,” said Governor Abbott. “UT MD Anderson Cancer Center is ranked No. 1 for cancer care in America, with people across the world traveling to Houston to access care. But rather than having Texans travel to MD Anderson in Houston, we will now bring the world’s best treatment to them. Families across Central Texas who are affected by cancer every year can now stay close to home for that care. The key to building sustainable communities is a healthcare infrastructure that can meet the needs of a booming population. UT Austin and MD Anderson will help us meet those needs. The Texas of tomorrow will be shaped by what UT Austin and MD Anderson are building here today.” 

Photo: Office of the Governor


The Governor was joined at the press conference by the UT System Board of Regents Chairman Kevin P. Eltife, UT System Chancellor James Milliken, UT Austin President Jay Hartzell, Dean and Senior Vice President for Medical Affairs for Dell Medical School at UT Austin M.D., Claudia F. Lucchinetti, and MD Anderson Cancer Center President Peter Pisters.

- Advertisement -

The UT MD Anderson Cancer Center will be staffed by MD Anderson physicians, increasing access to world-class cancer care to Central Texas patients. This partnership will take UT’s flagship campus and its Dell Medical School to the next level of research excellence, allowing both institutions to conduct research, educate the next generation of medical students, and enhance patient care. Last year, UT Austin and UT MD Anderson had a combined $1.8 billion in research, almost half of all the research expenditures across the UT system’s 13 institutions. 

Governor Abbot with UT Health System Officials. Photo: Office of the Governor
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Food Safety Tips for a Healthy Super Bowl Sunday

Super Bowl parties often feature takeout, delivery and foods that are served over several hours. To help prevent foodborne illness, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) is reminding fans to keep food safety in play on game day.

Researchers Develop Blood Test to Spot Early-Stage Cancers with High Accuracy

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, rather than the absolute level of those patterns as in other liquid biopsies.

Spanish researchers eliminate pancreatic tumors in mice using a three-drug therapy

A team of scientists at the Centro Nacional de Investigaciones Oncológicas (CNIO) has reported the complete elimination of pancreatic tumors in mice using a combination of three targeted drugs.

CDC Tops 1 Million Voluntary Participants in Traveler Genomic Surveillance Program

The Centers for Disease Control and Prevention (CDC) today announced that its Traveler-Based Genomic Surveillance (TGS) program has surpassed one million voluntary participants, marking a significant milestone in the United States' ability to detect and respond to emerging public health threats at our borders.
- Advertisement -
×